The Magazine for Sleep Professionals
Thursday, April 23, 2026
Takeda will present data from two global Phase 3 double-blind, placebo-controlled studies of oveporexton (TAK-861)1, a potential first-in-class investigational oral orexin receptor 2 (OX2R)-selective agonist in narcolepsy type 1 (NT1), during multiple oral presentations at the World Sleep 2025 Congress in Singapore. Both the FirstLight (TAK-861-3001) and RadiantLight (TAK-861-3002) […]
sovaSage™ Inc. announced a rebrand that underscores its evolution as a SaaS innovator. The refreshed brand identity includes a new tagline — “Guided by Data. Driven by Care.” — along with renamed product offerings that align with the company’s mission to optimize patient outcomes and streamline provider workflows. sovaSage continues […]
Attendees traveled from near and far to join us in person and online for the 2025 Wake Up Narcolepsy National Summit in Raleigh-Durham, N.C. Hosted in a different city each year, the summit provides a place where industry professionals, clinicians, individuals with narcolepsy, and family members can come together and […]
An estimated one in three adults worldwide experience symptoms of insomnia, yet only a fraction of those suffering have access to specialists trained in cognitive behavioral therapy for insomnia (CBTI)—the gold standard in treatment.1,2 This unmet need has created a major bottleneck in behavioral sleep medicine, where demand far exceeds […]
Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, and XWPharma Ltd. (“XWPharma”) together announced today that Avadel has entered into an exclusive global license agreement with XWPharma to develop and commercialize valiloxybate, a GABAB receptor agonist, for all indications, including the treatment of sleep disorders, such […]
Clinical Sleep Health Consulting, LLC (CSHCLLC), co-founded by frontline sleep navigators and national speakers Kelly Gladden, RRT, RPSGT, CCSH, RST, and Mrs. Donnie J. Brown-Hill, MPH, BS, CCSH, RPSGT, CPC, proudly announces its official soft launch on September 2, 2025. Built by clinicians who are still in scrubs, still on […]
My family loves to play games. One of the first things my husband and I bonded over was board games, and we passed that love of games to our children. As a family, we enjoy playing board games like Settlers of Catan and Carcassonne and card games like Dominion and […]
The global field of sleep medicine is at a critical inflection point, and at the heart of it lies a shared challenge—the shortage of qualified sleep technologists. With rising awareness of sleep disorders and their link to chronic health conditions, the demand for structured training and certification has surged, particularly […]
Noctrix Health, Inc., the developer of the Nidra® Tonic Motor Activation (TOMAC) therapy for Restless Legs Syndrome (RLS), announced a significant expansion of private financing to accelerate its U.S. commercial launch. The company also announced several key leadership appointments to strengthen its commercial and scientific teams. Financing Update Noctrix Health […]
Sleep medicine is undergoing a profound transformation. What was once centered around episodic, in-lab evaluations is evolving into a more continuous, personalized model of care. With the rapid rise of home sleep testing (HST) and increasingly sophisticated wearables, the integration of remote patient monitoring (RPM) into sleep medicine has moved […]
